semaglutide cause kidney stones and Stones: Know Your Risk Semaglutide and Kidney Health: Safety

In a meta-analysis of 48 randomized controlled trials SGLT2 inhibitors significantly increased LDL-C (3.8mg/dl, p 300 to 5000)

22:2451-2459 [PMC free article: PMC7756479] [PubMed: 33462955] 397

MedicalDaily Evidence Check Study type: Phase 3 randomized controlled trial (ATTAIN program) Participants: Adults with obesity or overweight with at least one weight-related comorbidity Approval date: April 1, 2026 What it found: Average weight loss of approximately 12.4% (about 27 lbs) at highest dose over 72 weeks What it did not prove: That it matches injectable GLP-1 efficacy

Very lean patients may benefit from pinching the skin to create a subcutaneous 'tent' or using a 45-degree angle to avoid intramuscular injection